Cerebrovascular Lesion Loads and Accelerated Brain Aging: Insights into the Cognitive Spectrum

Overview

Journal Front Dement

Date 2024 Jul 31

PMID 39081605

Authors

Iman Beheshti

Olivier Potvin

Mahsa Dadar

Simon Duchesne

Affiliations

Soon will be listed here.

Abstract

Introduction: White matter hyperintensities (WMHs) and cerebral microbleeds are widespread among aging population and linked with cognitive deficits in mild cognitive impairment (MCI), vascular MCI (V-MCI), and Alzheimer's disease without (AD) or with a vascular component (V-AD). In this study, we aimed to investigate the association between brain age, which reflects global brain health, and cerebrovascular lesion load in the context of pathological aging in diverse forms of clinically-defined neurodegenerative conditions.

Methods: We computed brain-predicted age difference (brain-PAD: predicted brain age minus chronological age) in the Comprehensive Assessment of Neurodegeneration and Dementia cohort of the Canadian Consortium on Neurodegeneration in Aging including 70 cognitively intact elderly (CIE), 173 MCI, 88 V-MCI, 50 AD, and 47 V-AD using T1-weighted magnetic resonance imaging (MRI) scans. We used a well-established automated methodology that leveraged fluid attenuated inversion recovery MRIs for precise quantification of WMH burden. Additionally, cerebral microbleeds were detected utilizing a validated segmentation tool based on the ResNet50 network, utilizing routine T1-weighted, T2-weighted, and T2 MRI scans.

Results: The mean brain-PAD in the CIE cohort was around zero, whereas the four categories showed a significantly higher mean brain-PAD compared to CIE, except MCI group. A notable association trend between brain-PAD and WMH loads was observed in aging and across the spectrum of cognitive impairment due to AD, but not between brain-PAD and microbleed loads.

Discussion: WMHs were associated with faster brain aging and should be considered as a risk factor which imperils brain health in aging and exacerbate brain abnormalities in the context of neurodegeneration of presumed AD origin. Our findings underscore the significance of novel research endeavors aimed at elucidating the etiology, prevention, and treatment of WMH in the area of brain aging.

References

Soldan A, Pettigrew C, Zhu Y, Wang M, Moghekar A, Gottesman R . White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease. Neurology. 2020; 94(9):e950-e960. PMC: 7238945. DOI: 10.1212/WNL.0000000000008864. View

Sachdev P, Kalaria R, OBrien J, Skoog I, Alladi S, Black S . Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014; 28(3):206-18. PMC: 4139434. DOI: 10.1097/WAD.0000000000000034. View

Duchesne S, Chouinard I, Potvin O, Fonov V, Khademi A, Bartha R . The Canadian Dementia Imaging Protocol: Harmonizing National Cohorts. J Magn Reson Imaging. 2019; 49(2):456-465. DOI: 10.1002/jmri.26197. View

Mishra S, Beheshti I, Khanna P . A Review of Neuroimaging-Driven Brain Age Estimation for Identification of Brain Disorders and Health Conditions. IEEE Rev Biomed Eng. 2021; 16:371-385. DOI: 10.1109/RBME.2021.3107372. View

Franke K, Gaser C . Ten Years of as a Neuroimaging Biomarker of Brain Aging: What Insights Have We Gained?. Front Neurol. 2019; 10:789. PMC: 6702897. DOI: 10.3389/fneur.2019.00789. View

Garnier-Crussard A, Cotton F, Krolak-Salmon P, Chetelat G . White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution. Alzheimers Dement. 2023; 19(8):3738-3748. DOI: 10.1002/alz.13057. View

Puy L, Pasi M, Rodrigues M, van Veluw S, Tsivgoulis G, Shoamanesh A . Cerebral microbleeds: from depiction to interpretation. J Neurol Neurosurg Psychiatry. 2021; . DOI: 10.1136/jnnp-2020-323951. View

Dadar M, Maranzano J, Misquitta K, Anor C, Fonov V, Tartaglia M . Performance comparison of 10 different classification techniques in segmenting white matter hyperintensities in aging. Neuroimage. 2017; 157:233-249. PMC: 6469398. DOI: 10.1016/j.neuroimage.2017.06.009. View

Dadar M, Duchesne S . Reliability assessment of tissue classification algorithms for multi-center and multi-scanner data. Neuroimage. 2020; 217:116928. DOI: 10.1016/j.neuroimage.2020.116928. View

10.

Sone D, Beheshti I . Neuroimaging-Based Brain Age Estimation: A Promising Personalized Biomarker in Neuropsychiatry. J Pers Med. 2022; 12(11). PMC: 9695293. DOI: 10.3390/jpm12111850. View

11.

Beheshti I, Nugent S, Potvin O, Duchesne S . Bias-adjustment in neuroimaging-based brain age frameworks: A robust scheme. Neuroimage Clin. 2019; 24:102063. PMC: 6861562. DOI: 10.1016/j.nicl.2019.102063. View

12.

Merino J . White Matter Hyperintensities on Magnetic Resonance Imaging: What Is a Clinician to Do?. Mayo Clin Proc. 2019; 94(3):380-382. DOI: 10.1016/j.mayocp.2019.01.016. View

13.

Gorelick P, Scuteri A, Black S, DeCarli C, Greenberg S, Iadecola C . Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(9):2672-713. PMC: 3778669. DOI: 10.1161/STR.0b013e3182299496. View

14.

Dadar M, Mahmoud S, Zhernovaia M, Camicioli R, Maranzano J, Duchesne S . White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts. Neuroimage Clin. 2022; 36:103204. PMC: 9668605. DOI: 10.1016/j.nicl.2022.103204. View

15.

Fortin J, Cullen N, Sheline Y, Taylor W, Aselcioglu I, Cook P . Harmonization of cortical thickness measurements across scanners and sites. Neuroimage. 2017; 167:104-120. PMC: 5845848. DOI: 10.1016/j.neuroimage.2017.11.024. View

16.

Cao Z, Mai Y, Fang W, Lei M, Luo Y, Zhao L . The Correlation Between White Matter Hyperintensity Burden and Regional Brain Volumetry in Patients With Alzheimer's Disease. Front Hum Neurosci. 2022; 16:760360. PMC: 9237397. DOI: 10.3389/fnhum.2022.760360. View

17.

Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View

18.

Lampe L, Kharabian-Masouleh S, Kynast J, Arelin K, Steele C, Loffler M . Lesion location matters: The relationships between white matter hyperintensities on cognition in the healthy elderly. J Cereb Blood Flow Metab. 2017; 39(1):36-43. PMC: 6311671. DOI: 10.1177/0271678X17740501. View

19.

Gaser C, Franke K, Kloppel S, Koutsouleris N, Sauer H . BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease. PLoS One. 2013; 8(6):e67346. PMC: 3695013. DOI: 10.1371/journal.pone.0067346. View

20.

Torbati M, Minhas D, Ahmad G, OConnor E, Muschelli J, Laymon C . A multi-scanner neuroimaging data harmonization using RAVEL and ComBat. Neuroimage. 2021; 245:118703. PMC: 8820090. DOI: 10.1016/j.neuroimage.2021.118703. View